Success Metrics

Clinical Success Rate
89.5%

Based on 51 completed trials

Completion Rate
89%(51/57)
Active Trials
0(0%)
Results Posted
16%(8 trials)
Terminated
6(9%)

Phase Distribution

Ph phase_3
17
26%
Ph phase_4
1
2%
Ph phase_1
9
14%
Ph phase_2
39
59%

Phase Distribution

9

Early Stage

39

Mid Stage

18

Late Stage

Phase Distribution66 total trials
Phase 1Safety & dosage
9(13.6%)
Phase 2Efficacy & side effects
39(59.1%)
Phase 3Large-scale testing
17(25.8%)
Phase 4Post-market surveillance
1(1.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

86.4%

51 of 59 finished

Non-Completion Rate

13.6%

8 ended early

Currently Active

0

trials recruiting

Total Trials

66

all time

Status Distribution
Completed(51)
Terminated(8)
Other(7)

Detailed Status

Completed51
unknown7
Terminated6
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
66
Active
0
Success Rate
89.5%
Most Advanced
Phase 4

Trials by Phase

Phase 19 (13.6%)
Phase 239 (59.1%)
Phase 317 (25.8%)
Phase 41 (1.5%)

Trials by Status

completed5177%
terminated69%
withdrawn23%
unknown711%

Recent Activity

0 active trials
Showing 5 of 66
completedphase_2

Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer

NCT00003042
completedphase_2

High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis

NCT00003353
terminatedphase_1

Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation

NCT00052884
completedphase_3

SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma

NCT00004031
completedphase_2

Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer

NCT00003270
View all 66 trials

Clinical Trials (66)

Showing 20 of 66 trialsScroll for more
NCT00003042Phase 2

Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer

Completed
NCT00003353Phase 2

High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis

Completed
NCT00052884Phase 1

Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation

Terminated
NCT00004031Phase 3

SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma

Completed
NCT00003270Phase 2

Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer

Completed
NCT00003727Phase 2

Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia

Completed
NCT00003397Phase 2

Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

Completed
NCT00046852Phase 1

Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma

Completed
NCT00003398Phase 4

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Completed
NCT00003401Phase 2

Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma

Completed
NCT00003402Phase 2

Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Completed
NCT00275015Phase 2

Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia

Completed
NCT00005987Phase 2

Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma

Terminated
NCT00101140Phase 2

Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission

Withdrawn
NCT00242996Phase 2

Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell Lymphoma

Completed
NCT00238433Phase 2

Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma

Completed
NCT00182793Phase 2

Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer

Completed
NCT00002931Phase 2

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer

Completed
NCT00003852Phase 2

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors

Terminated
NCT00003631Phase 2

Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma

Completed

Drug Details

Intervention Type
PROCEDURE
Total Trials
66